Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
NewAmsterdam Pharma Company N.V. (NAMS) had Return on Investments of -7.28% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$3.04M |
|
$-48.44M |
|
-- |
|
$3.04M |
|
$61.46M |
|
$-58.42M |
|
$9.98M |
|
$-48.44M |
|
$-48.44M |
|
$-48.44M |
|
$-48.44M |
|
$-48.44M |
|
$-48.44M |
|
$-58.42M |
|
$-58.36M |
|
121.72M |
|
121.72M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$658.04M |
|
$0.38M |
|
$74.60M |
|
$732.64M |
|
$67.42M |
|
-- |
|
-- |
|
$67.42M |
|
$665.22M |
|
$664.85M |
|
$665.22M |
|
116.64M |
|
| Cash Flow Statement Financials | |
$-30.60M |
|
$-11.51M |
|
$11.06M |
|
$491.32M |
|
$458.94M |
|
$-32.38M |
|
$18.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1921.71% |
|
-1921.71% |
|
-- |
|
-1593.45% |
|
-1593.45% |
|
$-30.64M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-7.28% |
|
-7.29% |
|
-6.61% |
|
|
Return on Investments |
-7.28% |
$5.70 |
|
$-0.25 |
|
$-0.25 |
|